Horizon Pharma Plc Stock Z Score
HZNPDelisted Stock | USD 100.40 0.13 0.13% |
Horizon |
Horizon Pharma PLC Company Z Score Analysis
Horizon Pharma's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Horizon Pharma Z Score | 7.48 |
Most of Horizon Pharma's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Horizon Pharma PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Horizon Pharma PLC has a Z Score of 7.48. This is 10.81% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The z score for all United States stocks is 14.22% higher than that of the company.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
Horizon Fundamentals
Return On Equity | 0.0854 | |||
Return On Asset | 0.0444 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.18 % | |||
Current Valuation | 26.87 B | |||
Shares Outstanding | 229 M | |||
Shares Owned By Insiders | 1.18 % | |||
Shares Owned By Institutions | 98.82 % | |||
Number Of Shares Shorted | 7.1 M | |||
Price To Earning | 32.55 X | |||
Price To Book | 5.10 X | |||
Price To Sales | 6.93 X | |||
Revenue | 3.63 B | |||
Gross Profit | 2.8 B | |||
EBITDA | 1.11 B | |||
Net Income | 521.48 M | |||
Cash And Equivalents | 2.13 B | |||
Cash Per Share | 9.40 X | |||
Total Debt | 2.56 B | |||
Debt To Equity | 0.53 % | |||
Current Ratio | 3.96 X | |||
Book Value Per Share | 23.20 X | |||
Cash Flow From Operations | 1.26 B | |||
Short Ratio | 2.04 X | |||
Earnings Per Share | 1.88 X | |||
Price To Earnings To Growth | 1.00 X | |||
Target Price | 116.5 | |||
Number Of Employees | 2.19 K | |||
Beta | 1.01 | |||
Market Capitalization | 26.63 B | |||
Total Asset | 9.11 B | |||
Retained Earnings | 590.01 M | |||
Working Capital | 2.7 B | |||
Current Asset | 1.11 B | |||
Current Liabilities | 357.55 M | |||
Z Score | 7.48 | |||
Net Asset | 9.11 B |
About Horizon Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Horizon Pharma PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Horizon Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Horizon Pharma PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Horizon Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Horizon Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Horizon Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Horizon Stock
Moving against Horizon Stock
0.85 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.75 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.7 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.66 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.66 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
The ability to find closely correlated positions to Horizon Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Horizon Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Horizon Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Horizon Pharma PLC to buy it.
The correlation of Horizon Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Horizon Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Horizon Pharma PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Horizon Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
Transaction History View history of all your transactions and understand their impact on performance | |
Stocks Directory Find actively traded stocks across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |